STRIDE INC (LRN) Stock Analyst Ratings
NYSE:LRN - New York Stock Exchange, Inc. - US86333M1080 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 84% to LRN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 165.71. This target is 15.68% above the current price.
LRN was analyzed by 11 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about LRN.
In the previous month the buy percentage consensus was at a similar level.
LRN was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-04-30 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-04-28 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-04-17 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-04-01 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-03-14 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-03-11 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-01-30 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-01-29 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-01-29 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-01-27 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-01-17 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-12-12 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-10-29 | Citigroup | Maintains | Neutral -> Neutral |
| 2024-10-24 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-10-23 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-10-23 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-10-11 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-09-20 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-08-20 | Citigroup | Downgrade | Buy -> Neutral |
| 2024-08-08 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-08-08 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-08-08 | Canaccord Genuity | Initiate | Buy |
| 2024-07-31 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-04-25 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-04-24 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-04-17 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-01-29 | Citigroup | Maintains | Buy -> Buy |
| 2024-01-25 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-01-24 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-01-24 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |